An approach to visualising pathway evidence
Please note that since the release of the Next-Generation Open Targets Platform [https://blog.opentargets.org/2021/04/29/next-gen-platform-released/], the REST API is no longer available. Check out the new Platform documentation [https://platform-docs.opentargets.org/data-access] for further details. The starting point in drug discovery is often a
Please note that since the release of the Next-Generation Open Targets Platform , the REST API is no longer available. Check out the new Platform documentation for further details. The starting point in drug discovery is often a specific target or disease. But what if instead you have a specific pathway to start with? As part of an Open Targets research project on the complement system pathway, I wanted to find approaches to visualise genetic evidence and still maintain information about its mechanisms. This is particularly relevant for the complement pathway: although functional genetic varia
Explore this link on the map →related reading
- Gap Mapgap-map.org
- the drug landscapegenome-browser-eight.vercel.app
- Systematic integration of biomedical knowledge prioritizes drugs for repurposinggit.dhimmel.com
- Mnemonic portraits for 19,023 human genes — LessWronglesswrong.com
- Overview | Human Brain Pharmacomepharmacome.github.io
- The 23andMe Deal - Cremieux Recueilcremieux.xyz
- AOP-DB: A database resource for the exploration of Adverse Outcome Pathways through integrated association networks - PMCncbi.nlm.nih.gov
- Connecting the dots in early drug discovery at Novartisneo4j.com
- GitHub - Illumina/SpliceAI: A deep learning-based tool to identify splice variants · GitHubgithub.com
- An experimentally validated approach to automated biological evidence generation in drug discovery using knowledge graphs | Nature Communicationsnature.com
- Nature's drug database - The Works in Progress Newsletterworksinprogress.news
- AlphaProteo generates novel proteins for biology and health research — Google DeepMinddeepmind.google